BioUtah Member Deals

Life-Sciences D&O Insurance with Pre-Negotiated Coverage for FDA Actions and Clinical Trial Litigation.

Standard D&O policies exclude the risks life sciences companies actually face—FDA enforcement, trial failures, and HIPAA breaches. Aon’s BIO program delivers competitive rates on policies built specifically for biotech, with pre-negotiated enhancements for regulatory and securities risk.

Offers Available to BioUtah Members:

• FDA enforcement action coverage (excluded from most standard D&O policies)
• Clinical trial failure and adverse event protection
• SPAC and de-SPAC transaction coverage during complex capital events
• Side A protection when the company can't indemnify directors